Reply
- PMID: 33164325
- DOI: 10.1002/art.41579
Reply
Comment on
-
Safety and Efficacy of Lenabasum in a Phase II, Randomized, Placebo-Controlled Trial in Adults With Systemic Sclerosis.Arthritis Rheumatol. 2020 Aug;72(8):1350-1360. doi: 10.1002/art.41294. Epub 2020 Jul 17. Arthritis Rheumatol. 2020. PMID: 32336038 Free PMC article. Clinical Trial.
-
Lenabasum for Systemic Sclerosis-Are Cannabinoids the Missing Link? Comment on the Article by Spiera et al.Arthritis Rheumatol. 2021 Apr;73(4):715-716. doi: 10.1002/art.41578. Epub 2021 Feb 18. Arthritis Rheumatol. 2021. PMID: 33164286 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical